Protara Therapeutics: Fourth Quarter Earnings Overview
Protara Therapeutics Announces Fourth Quarter Financial Results
Protara Therapeutics, headquartered in New York, disclosed a net loss of $17.3 million for the fourth quarter.
The company reported a quarterly loss of $0.37 per share.
This performance fell short of analysts’ expectations, as a consensus of five analysts polled by Zacks Investment Research had predicted a loss of $0.32 per share.
For the entire year, Protara Therapeutics posted a total loss of $57.4 million, translating to $1.34 per share.
Financial data for this article was sourced from Zacks Investment Research and processed by Automated Insights.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Intel's 2.63% Rebound Drives 17th-Highest Trading Volume on AI Innovations and Strategic Deals
GE Vernova Rises 1.1% on Strong Q4 Results Volume Ranks 43rd at $2.01 Billion Despite Mixed Q1 Outlook
Sei Gains Momentum — What’s Next for SEI Price as Its Financial L1 Expands?

Breaking: Oil Prices Climb as Iran Set To Deploy Mines at Strait of Hormuz

